Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia

npj Vaccines · Published 2026-07-20 · DOI 10.1038/s41541-026-01525-6

Free full text

Authors (25)

Sabryna Nantel, Samuel Sassine, Benoîte Bourdin, Margot Barbosa Da Torre, Gabrielle Sutton, Henintsoa Rabezanahary, Freda Qi, Lesley A. Ward, Melanie Delgado-Brand, Kelsey Adams, Salma Sheikh-Mohamed, Louise Wang, Sylvie Nicholson, Zineb Laghdir, Karen Colwill, Gary Chao, Laurie Seifried, Ying Liu, James M. Rini, Jennifer Gommerman, Anne-Claude Gingras, Mariana Baz, Kate Zinzser, Caroline Quach, Hélène Decaluwe

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Nantel, S., Sassine, S., Bourdin, B., et al. (2026). Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia. npj Vaccines. https://doi.org/10.1038/s41541-026-01525-6

Related articles

• Maturation-deficient chikungunya virus elicits protective immune responses in a murine challenge model · npj Vaccines · 2026 · Same journal
• Recent advances in Epstein–Barr virus vaccines development from mechanistic exploration to clinical translation · npj Vaccines · 2026 · Same journal
• Maternal influenza vaccination boosts durable breast milk antibody-mediated protection in infants · npj Vaccines · 2026 · Same journal
• Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities · npj Vaccines · 2026 · Same journal
• Suppressor tRNA-mediated conditionally replicating live vaccine effectively protects pigs against Seneca Valley virus challenge · npj Vaccines · 2026 · Same journal
• Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy · npj Vaccines · 2026 · Same journal
• Post-exposure vaccination with an adjuvanted protein subunit vaccine, but not BCG, protects mice and guinea pigs against M. tuberculosis · npj Vaccines · 2026 · Same journal
• Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis · npj Vaccines · 2026 · Same journal
• Safety and immunogenicity testing of a melioidosis subunit vaccine candidate in cynomolgus macaques · npj Vaccines · 2026 · Same journal
• Modeling time-varying efficacy of RTS,S/AS01 malaria vaccine across trial settings · npj Vaccines · 2026 · Same journal